期刊文献+

多巴胺受体激动剂治帕金森病的临床研究进展 被引量:2

原文传递
导出
摘要 本文对多巴胺受体激动剂的分类、作用机制、临床疗效、不良反应、应用方式以及临床上如何正确选择多巴胺受体激动剂作了系统阐述,强调了多巴胺受体激动剂在帕金森病治疗中的重要地位,尤其在疾病早期就作为单药使用的优越性。
出处 《国外医学(神经病学.神经外科学分册)》 2004年第6期515-518,共4页 Foreign Medical Sciences(Section On Neurology & Neurosurgery)
  • 相关文献

参考文献16

  • 1CE Clark, M Guttman. Dopamine agonist monotherapy in Parkinson's disease.The Lancet,2002,360(9347) : 1767 - 1770.
  • 2Olanow CW, Watts RL, Koller WC. An algorithm ( decision tree) for the management d Parkinson ' s disease .( 2001 ) : treament guidelines.Neurology, 2001,56(Suppl 5 ) : S1 - S88.
  • 3Eng - King Tan, Joseph Jankovic. Choosing Dipamine Agonists in Parkinson' s Disease. Clinical Neuropharmacology, 2001,24(5) : 247 -253.
  • 4Peter Jenner, DSc, FBPharmS. Pharmacology of dopamine agonists in the treatment of Parkinson' s disease. Neurology,2002,58(Suppl 1) : S1 -S8.
  • 5Perachon S, Schawartz JC, Sokoloff P. Functional potencies of new antlparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors. Eur J Pharmaco 1999 ;366:293 - 300,.
  • 6Hershey T, Black KJ, Carl JL, et al. long term treatment and disease severity change brain responses to levodpa in Parkinson' s disease Journal d Neurology, Neumsurgery & Psychiatry,2003,74(7) :844.
  • 7Nutt JG, Obeso JA, Stocchi F. Continuous dopamine- receptor stimulation in advanced Parkinson's disease. Trends Neurme 2000;23(suppl) :S109 - 115.
  • 8Olanow WC, Schapira AHV, Bascol O. Confinous doimmine-rvceptor stimulation in early Parkinson disease. Trends Nemmsci, 2003, 23(Suppl) :Sl17 - 126.
  • 9C Lebnm - Frenay, M Borg. Choosing the right dopamine agonist for patients with Parkinson' s disease. Current Medical Research and Opinion 2002; 18(4) :209 - 215.
  • 10J.M. Miyasaki, W. Martin, O. Suchowersky, et al. Practice pmanmter:Initiation of treatment for Parkimon' s disease: An evidence - baaed review. Amer Aca Neurol, 2002; 58 January(1ot2) : 11 - 17.

同被引文献9

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部